about
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product can...
Read More
1.87
-0.04
(-2.09%)
236.0K
XNAS Volume
XNAS 17 Jul, 2026 12:31 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
InflaRx N.V. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..